Provided by Tiger Trade Technology Pte. Ltd.

Arcutis Biotherapeutics Inc.

23.89
+0.50502.16%
Post-market: 23.890.00000.00%16:10 EDT
Volume:2.04M
Turnover:48.89M
Market Cap:2.99B
PE:110.88
High:24.18
Open:23.63
Low:23.55
Close:23.38
52wk High:31.77
52wk Low:16.57
Shares:125.07M
Float Shares:111.18M
Volume Ratio:0.90
T/O Rate:1.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2154
EPS(LYR):-0.1269
ROE:15.86%
ROA:5.09%
PB:13.54
PE(LYR):-188.28

Loading ...

Sep 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 28, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 05, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2026

Major Issues Report

Form 8-K - Current report
Aug 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 17, 2026

Major Issues Report

Form 8-K - Current report
Jul 16, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 09, 2026

Major Issues Report

Form 8-K - Current report
May 12, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors